Abstracts

Long-Term Effect of Temporary ART During Primary HIV Infection on the Viral Reservoir

Background: Initiation of antiretroviral therapy (ART) during primary HIV-1 infection (PHI) has been proposed to limit the formation of viral reservoirs. However, it remains unknown whether temporary ART during PHI has a long-term effect on the viral reservoir during ART initiated subsequently at chronic HIV infection (CHI). Methods: Levels of cell-associated (CA) HIV-1 unspliced RNA…

Siglec-1 on Monocytes From Untreated HIV-1–Infected Patients Enhances HIV-1 Transfer

Background: The IFNα-inducible receptor Siglec-1 (CD169) is expressed on myeloid cells and recognizes HIV-1 membrane gangliosides, enhancing viral uptake and cell-to-cell transmission. Moreover, Siglec-1 is upregulated on monocytes of HIV-1-infected-individuals with high viral loads. However, if Siglec-1 expressed on monocytes from HIV-1-infected patients mediates viral transmission is still unknown. Here, we aim to study the…

Soluble CD40 Ligand Contributes to Dendritic Cell Mediated T-Cell Dysfunction

Background: Soluble CD40 ligand (sCD40L) levels are increased during human immunodeficiency virus (HIV) infection, but it is unknown whether monomeric or multimeric forms predominate, and whether there are differential effects of these forms on dendritic cell function and dendritic cell-T cell interactions. Methods: Immunoblots were performed to delineate various forms of sCD40L present in plasma…

The Alarmin HMGB1 Is Crucial for the Acquisition of Antiviral pDC Effector Functions

Background: Plasmacytoid dendritic cells (pDCs) are the main producers of interferon-alpha (IFNα), a powerful innate antiviral cytokine. IFNα production by pDCs is promoted by their cross-talk with NK cells, which triggers NK cell-cytotoxicity through the up-regulation of the death ligand TRAIL. HIV-1 directly activates pDCs by inducing their maturation and their production of IFNα. HIV-1…

Dysfunctional Neutrophil Responses to SIV Infection

Background: Recent studies indicate that individuals with low neutrophils (PMN) are at increased risk of HIV infection. Also, the RV144 vaccine trial implicated non-neutralizing antibodies and associated Fc-mediated functions in vaccine-induced protection. These studies suggest that early innate antiviral functions and Fc-mediated functions of PMN may play an important role in mediating early viral control,…

HIV-Exposed Seronegative MSM Have Increased Novel Antiviral Factors in Rectal Mucosa

Background: HIV-Exposed Seronegative (HESN) individuals have shown altered mucosal immune responses in cervical, salivary and foreskin secretions associated with reduced HIV-susceptibility; however, this has not been investigated in rectal mucosa. As the rectal compartment is a major portal of entry for HIV understanding site-specific immune responses is important for biomedical prevention research. Advances in proteomic…

PBMC From Highly Exposed Seronegative Individuals Inhibit Transmitted Founder HIV

Background: Highly-exposed Sero-Negative (HESN) individuals engage frequently in unprotected sexual activities, yet remain sero-negative. In order to avoid sero-conversion, these individuals likely restrict HIV infection soon after transmission. Transmission of HIV infection is established by an extremely small fraction of circulating virus. These Transmitted Founder viruses (TFV) likely arise from a single HIV clone. Recently,…

HIV-1-Exposed Seronegative Persons Have Lower Mucosal Innate Immune Reactivity

Background: Mucosal transmission accounts for the majority of HIV infections, yet is a poorly understood event. Risk of HIV acquisition varies, and there are some individuals who appear to remain uninfected despite repeated high-risk sexual exposures, termed HIV-exposed seronegative (HESN). The immunologic factors contributing to this phenomenon are an area of intense interest. It is…

Increased Levels of Regulatory T-cells Correlate With Protection From HIV Infection

Background: An important challenge related to the development of an HIV vaccine is the lack of known correlates of protection from infection. Individuals who remain seronegative despite repeated HIV exposures (HIV-exposed seronegatives, HESN) offer a relevant model in which to identify correlates of protection. One of the proposed mechanisms of protection from HIV infection is…

Estimating the Respective Contributions of Human and Viral Genetic Variation to HIV Control

Background: Viral load setpoint is a major correlate of HIV disease progression. Genome-wide association studies have identified common human polymorphisms that together explain no more than 15% of its phenotypic variance. Concurrently, studies of the impact of HIV genetic diversity on viral load have produced highly variable estimates. Here we present a joint assessment of…